Cancer Therapeutics
Helsinn is moving into cancer therapeutics because we have identified a real patient need area. We also believe that our unique understanding of cancer patients and their journey provides us with a particular insight.
Valchlor®/Ledaga®
Valchlor®/Ledaga® (mechlorethamine/chlormethine) is a nitrogen mustard alkylating agent for the topical treatment of mycosis fungoides‐type cutaneous T‐cell lymphoma (MF-CTCL). Valchlor®/Ledaga® gel is applied topically once-a-day and dries on the skin. Valchlor® is the first and only US FDA approved topical formulation of mechlorethamine, while Ledaga® is the topical formulation of chlormethine and the first chemotherapy gel specifically approved for MF-CTCL by EMA.
Valchlor®/Ledaga®
Valchlor®/Ledaga® (mechlorethamine/chlormethine) is a nitrogen mustard alkylating agent for the topical treatment of mycosis fungoides‐type cutaneous T‐cell lymphoma (MF-CTCL). Valchlor®/Ledaga® gel is applied topically once-a-day and dries on the skin. Valchlor® is the first and only US FDA approved topical formulation of mechlorethamine, while Ledaga® is the topical formulation of chlormethine and the first chemotherapy gel specifically approved for MF-CTCL by EMA.